GENENTA Aktie

>GENENTA Performance

1 Woche: -7,8%

1 Monat: -25,7%

3 Monate: -56,9%

6 Monate: -78,6%

1 Jahr: -82,9%

laufendes Jahr: -56,9%

>GENENTA Aktie

Name:

GENENTA SCIENCE(SP.ADR)/1

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US36870W1009 / A3C9EK

Symbol/ Ticker:

K5F (Frankfurt) / GNTA (NASDAQ)

Kürzel:

FRA:K5F, ETR:K5F, K5F:GR, NASDAQ:GNTA

Index:

Webseite:

https://www.genenta.com/

Profil:

Genenta Science S.p.A. is a biotechnology company focused on developing innovative therapies for cancer treatment. As an emerging leader in the field of immuno-gene therapy, Genenta Science aims to harness the body's immune system to combat and eradi..
>Volltext..

Marktkapitalisierung:

11.56 Mio. EUR

Unternehmenswert:

Umsatz:

EBITDA:

Nettogewinn:

Gewinn je Aktie:

Schulden:

Liquide Mittel:

Operativer Cashflow:

Bargeldquote:

Umsatzwachstum:

Gewinnwachstum:

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

GENENTA

Letzte Datenerhebung:

05.04.26

>GENENTA Kennzahlen

Aktien/ Unternehmen:

Aktien: 19.15 Mio. St.

Frei handelbar: -

Leerverk. Aktien: 0.24%

Rückkaufquote: -

Mitarbeiter: 13

Umsatz/Mitarb.: -

Analysten:

Analystenrating: No rating

Kursziel: -

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: -

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -

Eigenkaprendite: -

>GENENTA Peer Group

Gesundheit, Zell- & Gentherapie/ Gentechnik/ Erbkrankheiten, Onkologie/ Krebs- Behandlung

>GENENTA Chart & Kurs - NASDAQ

>GENENTA News

27.03.26 - 10:06	Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe′s space and defense programs (GlobeNewswire EN)
	Genenta has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs...

24.03.26 - 08:30	Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini (GlobeNewswire EN)
	Focused on selective acquisitions of high-quality companies in strategic industrial sectors Focused on selective acquisitions of high-quality companies in strategic industrial sectors...

13.03.26 - 10:03	Genenta, Evolving into Saentra Forge, Announces CEO′s Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University (GlobeNewswire EN)
	Genenta, Evolving into Saentra Forge, Announces CEO's Appointment to the Board of Guarantors of the Italian Academy at Columbia University...

27.02.26 - 10:03	Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform (GlobeNewswire EN)
	Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform...

27.01.26 - 15:48	Strategiewechsel in Rüstungssektor treibt Aktie von Genenta Science an (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

27.01.26 - 09:03	Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator (GlobeNewswire EN)
	Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator...

19.12.25 - 08:36	Genenta Science Provides Update on CEO Ownership (GlobeNewswire EN)
	Genenta Science Provides Update on CEO Ownership...

24.11.25 - 15:06	Aktie von Genenta Science schießt nach Update zu Glioblastom-Studie in die Höhe (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

24.11.25 - 10:03	Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial (GlobeNewswire EN)
	Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor Trial. Approximately $30 Million in Cash and Short-Term investments...

20.11.25 - 05:45

Earnings Momentum Lifts PACS And Nutex; Zynex And Genenta Also Advance After Hours (RTTNews)

Several stocks posted notable moves in Wednesday's after-hours session, extending momentum from the regular trading day or reversing earlier trends. Earnings announcements and recent financing updates shaped activity across healthcare, biotech, and technology names, with PACS Group and Nutex Health standing out on fresh quarterly results. Below is a look at the companies making headlines after the close....

27.10.25 - 15:01	Aktie von Genenta Science stürzt nach 15-Millionen-Dollar-Kapitalerhöhung ab (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

27.10.25 - 08:24	Genenta Science jumps on $15M direct offering (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

27.10.25 - 01:33	Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares (GlobeNewswire EN)
	Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares...

24.10.25 - 15:12	Strategische Kooperation bei Plasmid-DNA-Technologie lässt Aktie von Genenta Science explodieren/n (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

24.10.25 - 10:03	Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production (GlobeNewswire EN)
	GENENTA AND ANEMOCYTE ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE OFF-THE-SHELF LVV PLASMID DNA PRODUCTION...

01.07.25 - 11:03	Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals (GlobeNewswire EN)
	Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals...

08.05.25 - 13:06	D.Boral Capital: Genenta Science, SpA Announces Participation in the D. Boral Capital Inaugural Global Conference (Newsfile)
	Milan, Italy and New York, New York--(Newsfile Corp. - May 8, 2025) - Genenta Science, SpA (NASDAQ: GNTA), today announced its participation in the D. Boral Capital Inaugural Global Conference, ta......

15.04.25 - 11:03	Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar (GlobeNewswire EN)
	CEO Genenta Science (Nasdaq: GNTA) will present at “Montalcini Global Biotech Tour Doha April 17, 2025...

19.03.25 - 14:30	Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates (GlobeNewswire EN)
	Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram